Silence Therapeutics plc (SLN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -15.6M | -17.29M | -10.89M | -21.78M | -12.31M | -22.06M | -19.66M | -5.41M | -9.14M | -11.87M | -4.87M | -14.96M | -7.66M | -13.41M | -9.4M | -8.27M | -14.38M | -2.21M | -4.93M | 26.03M |
| Operating CF Margin % | -3703.61% | -50844.12% | -6849.69% | -9725% | -8668.31% | -90.69% | -1721.19% | -904.52% | -58.24% | -565.32% | -174.12% | -164.28% | -67.31% | -281.39% | -278.97% | -226.96% | -251.24% | -64.59% | -156.12% | 963.75% |
| Operating CF Growth % | -26.76% | 21.65% | 44.59% | -302.74% | -34.63% | -85.93% | -303.45% | 63.83% | -19.42% | 11.5% | 48.19% | -80.89% | 46.74% | -508.07% | -90.87% | -131.76% | -18.88% | 59.22% | - | 6127.51% |
| Net Income | -14.96M | -82.17M | -20.96M | -27.35M | -22.08M | 22.89M | -41.88M | -19.75M | -2.31M | -14.97M | -10.66M | -10.4M | -12.67M | -15.05M | -9.33M | -13.42M | -7.68M | -11.23M | -12.05M | -12.71M |
| Depreciation & Amortization | 72K | 509K | 156K | 148K | 138K | 119.28K | 115K | 150K | 152K | 121K | 125K | 118K | 134K | 141K | 114K | 114K | 113K | 66K | 110K | 123K |
| Stock-Based Compensation | 2.45M | 7.27M | 2.54M | 2.08M | 2.74M | 3.42M | 3.1M | 4.14M | 4.12M | 1.5M | 3.85M | 3M | 4.69M | 1.73M | 2.39M | 3.06M | 3.08M | 1.84M | 2.58M | 2.72M |
| Deferred Taxes | 0 | 10K | 1K | 10K | 0 | 0 | 0 | 0 | 0 | 940K | 179K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -514.45K | 60.74M | 2.16M | 7.83M | 150.22K | -22.17M | 18.76M | -878K | -778K | 1.67M | -2.04M | 1.82M | 7.46M | 5.02M | -4.55M | -785K | -6.95M | 495K | 3.88M | 758K |
| Working Capital Changes | -2.65M | -3.65M | 5.21M | -4.5M | 6.75M | -26.32M | 253.54K | 10.93M | -10.32M | -1.13M | 3.67M | -9.49M | -7.27M | -5.24M | 1.97M | 2.76M | -2.93M | 6.62M | 546K | 35.14M |
| Change in Receivables | -208.65K | 159.11K | -6.28M | -2M | 727.63K | -2.09M | 1.39M | 5.23M | -1.23M | 234K | 11.86M | -11M | -778K | -785K | 2.77M | -327K | -2.24M | -1.82M | 438K | 33.27M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.94M | -2.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 10M | -53.34M | 51.29M | -1.56M | -44.38M | 49.78M | -28.84M | -43K | -49.91M | 382K | 20.63M | -4.71M | 128K | -16.41M | -42K | -35K | -51K | 4.45M | 4.67M | -436K |
| Capital Expenditures | 0 | -55K | -3K | -48K | -4K | -55.77K | -49K | -85K | 0 | -1K | -20K | 3K | -33K | -303K | -47K | -37K | 0 | -527K | -331K | -439K |
| CapEx % of Revenue | - | 161.76% | 1.89% | 21.43% | 2.82% | 0.23% | 4.29% | 14.21% | - | 0.05% | 0.71% | 0.03% | 0.29% | 6.36% | 1.39% | 1.02% | - | 15.44% | 10.49% | 16.25% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 124.74K | 86.57M | 51.29M | 0 | 25.68M | -20.34M | 19.82M | 0 | 0 | 383K | 546K | -4.71M | 161K | -16.11M | 5K | 4K | -51K | 4.98M | 5M | 3K |
| Cash from Financing | 0 | -14 | 0 | 1K | 14K | 1.12M | 5.97M | 1.19M | 133.02M | 9.92M | 12.03M | 3.18M | 19K | 44K | 43.06M | -11K | -47K | 0 | 425K | -62K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 49K | -49K | -122.69K | 0 | -43K | -49K | -34K | -48K | -78K | -15K | -50K | -47K | -1K | 406K | -502K |
| Equity Issued (Net) | 0 | -14 | 0 | 1K | 14K | -17.68M | 16.78M | 1.19M | 133.02M | 9.96M | 12.08M | 0 | 67K | 122K | 43.08M | 39K | 0 | 1K | 19K | 440K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 18.75M | -10.76M | 122.69K | 0 | 0 | 0 | 3.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -5.6M | -70.75M | 40.29M | -23.15M | -56.44M | 59.38M | -47.53M | -4.27M | 73.93M | -4.78M | 29.09M | -17.01M | -8.09M | -35.2M | 38.45M | -7.73M | -14.24M | 2.07M | 231K | 25.51M |
| Free Cash Flow | -15.6M | -17.34M | -10.89M | -21.83M | -12.31M | -24.92M | -19.7M | -5.49M | -9.14M | -11.87M | -4.89M | -14.95M | -7.69M | -13.71M | -9.45M | -8.3M | -14.38M | -2.75M | -5.26M | 25.59M |
| FCF Margin % | -3703.61% | -51005.88% | -6851.57% | -9746.43% | -8671.13% | -102.43% | -1725.48% | -918.73% | -58.24% | -565.36% | -174.84% | -164.25% | -67.6% | -287.74% | -280.36% | -227.97% | -251.24% | -80.7% | -166.6% | 947.5% |
| FCF Growth % | -26.72% | 30.41% | 44.71% | -297.38% | -34.67% | -109.99% | -302.8% | 63.26% | -18.91% | 13.45% | 48.24% | -80.05% | 46.52% | -397.68% | -79.75% | -132.45% | -18.74% | 49.95% | - | 11480.09% |
| FCF per Share | -0.33 | -0.37 | -0.69 | -1.39 | -0.78 | -1.60 | -1.26 | -0.35 | -0.62 | -0.90 | -0.39 | -1.24 | -0.64 | -1.14 | -0.86 | -0.83 | -1.44 | -0.09 | -0.18 | 0.86 |
| FCF Conversion (FCF/Net Income) | 1.04x | 1.47x | 0.52x | 0.80x | 0.43x | -1.56x | 0.73x | 0.35x | 3.95x | 0.82x | 0.59x | 1.44x | 0.75x | 0.97x | 1.32x | 0.69x | 1.87x | 0.23x | 0.50x | -2.24x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 7K | 121K | 433K | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |